```html

Watermelon Stomach (Gastric Antral Vascular Ectasia)

Overview

Watermelon stomach is the lay‑term for gastric antral vascular ectasia (GAVE). It is a condition in which fragile, dilated blood vessels form in the lining of the stomach’s antrum (the lower portion). The vessels appear as long, reddish streaks that radiate outward, resembling the stripes on a watermelon, hence the nickname.

GAVE is an uncommon cause of chronic gastrointestinal bleeding, accounting for about 4–5 % of all non‑variceal upper GI bleeding and up to 30 % of bleeding in patients with systemic sclerosis.<sup>[1][2]</sup> It most frequently affects adults over age 50, and women are slightly more likely to develop it than men.

Because the bleeding is often slow and intermittent, many patients are unaware they have GAVE until they develop iron‑deficiency anemia or require a blood transfusion.

Symptoms

Symptoms result from chronic blood loss, local irritation of the stomach lining, or, rarely, acute hemorrhage. Common manifestations include:

• Fatigue and weakness – due to anemia.
• Dizziness or light‑headedness – especially on standing.
• Pale skin or nail beds – a classic sign of low hemoglobin.
• Shortness of breath on exertion – anemia reduces oxygen delivery.
• Melena (black, tarry stools) – indicates digested blood from the upper GI tract.
• Occult blood in stool – detectable only on laboratory testing.
• Epigastric discomfort – a vague ache or fullness after meals; not always present.
• Unexplained weight loss – may occur if patients avoid eating because of discomfort.
• Acute vomiting of blood (hematemesis) – rare but signals a sudden, severe bleed.

Causes and Risk Factors

The exact cause of GAVE remains unclear, but several mechanisms and associated conditions have been identified:

Underlying Pathophysiology

• Abnormal dilation of mucosal capillaries and venules in the gastric antrum.
• Increased local production of prostaglandins and vascular endothelial growth factor (VEGF) leading to fragile vessels.
• Chronic mechanical stress from gastric peristalsis may contribute to vessel distortion.

Associated Conditions (Risk Factors)

• Systemic sclerosis (scleroderma) – present in 30–50 % of GAVE cases.<sup>[2]</sup>
• Cirrhosis and chronic liver disease – portal hypertension may aggravate mucosal vascular changes.
• Chronic kidney disease & hemodialysis – uremic toxins may affect vascular integrity.
• Autoimmune disorders such as systemic lupus erythematosus.
• Cardiac conditions – especially congestive heart failure with low‑output states.
• Elderly age – vascular fragility rises with age.
• Use of anticoagulants or antiplatelet agents – can exacerbate bleeding once GAVE is present.

Diagnosis

Diagnosing GAVE involves a combination of clinical suspicion, laboratory testing, and direct visualization of the stomach lining.

Step‑by‑Step Diagnostic Approach

1. History and physical examination – Look for anemia‑related symptoms and risk‑factor clues (e.g., scleroderma).
2. Blood tests – Complete blood count (CBC) to evaluate hemoglobin/hematocrit, iron studies (ferritin, transferrin saturation), and vitamin B12/folate levels.
3. Stool occult blood test – Detects hidden blood when melena is absent.
4. Upper endoscopy (esophagogastroduodenoscopy, EGD) – Gold‑standard. The endoscopist visualizes the characteristic “watermelon‑stripe” lesions in the gastric antrum and may obtain biopsies.
5. Endoscopic biopsy – Histology shows ectatic capillaries, fibrin thrombi, and fibromuscular hyperplasia. Biopsy helps rule out other causes like gastric cancer or portal hypertensive gastropathy.
6. Imaging (optional) – CT or MRI may be ordered to evaluate for liver disease or portal hypertension, which can coexist.

In most centers, diagnosis is confirmed when endoscopic appearance matches GAVE and other sources of bleeding are excluded.

Treatment Options

Treatment is aimed at controlling bleeding, correcting anemia, and addressing any underlying disease.

Medical Management

• Iron supplementation – Oral ferrous sulfate (325 mg three times daily) or intravenous iron for patients who cannot tolerate oral therapy.
• Erythropoiesis‑stimulating agents (ESAs) – Considered in chronic kidney disease patients with anemia.
• Proton‑pump inhibitors (PPIs) – May provide mucosal protection, though evidence of direct benefit in GAVE is limited.
• Hormonal therapy (e.g., estrogen‑progesterone) – Historically used; modern practice favors endoscopic methods due to limited efficacy and side‑effects.

Endoscopic Therapies (First‑Line)

1. Argon plasma coagulation (APC) – Non‑contact thermal coagulation that cauterizes bleeding vessels. Success rates of 70‑90 % for reducing transfusion needs.<sup>[3]</sup>
2. Radiofrequency ablation (RFA) – Delivers controlled heat; newer data show durable remission with fewer sessions compared with APC.
3. Endoscopic band ligation (EBL) – Similar to variceal banding; useful for focal lesions.
4. Cryotherapy – Emerging technique; limited but promising results.

Surgical Options (Reserved for Refractory Cases)

• Antrectomy – Removal of the antrum; can be curative but carries surgical risk and is rarely performed.
• Subtotal gastrectomy – Considered when extensive disease is unresponsive to endoscopic therapy.

Adjunct Lifestyle & Medication Adjustments

• Review and possibly discontinue unnecessary anticoagulants or antiplatelet drugs in consultation with the prescribing physician.
• Optimize management of co‑existing liver or kidney disease.

Living with Watermelon Stomach

Even after successful treatment, many patients need ongoing self‑care to prevent recurrence.

Daily Management Tips

• Monitor hemoglobin – Check CBC every 3–6 months or sooner if symptoms return.
• Take iron as directed – Pair oral iron with vitamin C (e.g., a glass of orange juice) to improve absorption; avoid calcium‑rich foods within two hours of the dose.
• Stay hydrated – Adequate fluids help maintain gastrointestinal mucosal health.
• Balanced diet – Emphasize lean protein, leafy greens, and whole grains; limit very spicy or acidic foods if they provoke discomfort.
• Regular follow‑up endoscopy – Usually every 12–24 months after endoscopic therapy, or earlier if anemia recurs.
• Medication review – Keep an updated list of all drugs, especially over‑the‑counter NSAIDs, which can worsen bleeding.

Psychosocial Considerations

Chronic anemia can affect mood and energy levels. Encourage patients to discuss fatigue or depression with their provider. Support groups for autoimmune or liver disease patients often include members with GAVE, providing peer encouragement.

Prevention

Because the root causes (e.g., systemic sclerosis) cannot be eliminated, prevention focuses on risk‑reduction and early detection:

• Control underlying diseases – Tight control of scleroderma skin and organ involvement, optimal management of cirrhosis, and dialysis adequacy.
• Limit NSAID and aspirin use – If pain relief is needed, discuss alternatives such as acetaminophen with a physician.
• Regular screening in high‑risk groups – Patients with systemic sclerosis or advanced liver disease should have baseline CBC and consider periodic endoscopy if anemia develops.
• Vaccinations – For liver disease patients, hepatitis A and B vaccines reduce the chance of further hepatic injury that could exacerbate portal hypertension.

Complications

If left untreated or if bleeding is uncontrolled, GAVE can lead to serious health problems:

• Severe iron‑deficiency anemia – May require frequent blood transfusions, which carry infection and alloimmunization risks.
• Cardiovascular strain – Chronic anemia can precipitate tachycardia, high‑output heart failure, or worsen existing cardiac disease.
• Acute gastrointestinal hemorrhage – Sudden massive bleeding can cause hypovolemic shock.
• Nutritional deficiencies – Ongoing blood loss can impair absorption of iron, folate, and vitamin B12.
• Reduced quality of life – Persistent fatigue limits daily activities and may lead to depression.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Gastric antral vascular ectasia (GAVE).” Accessed March 2024. https://www.mayoclinic.org/diseases-conditions/gastric-antral-vascular-ectasia
2. American College of Rheumatology. “Systemic sclerosis and gastrointestinal involvement.” 2023. https://www.rheumatology.org/Practice-Guide/Systemic-Sclerosis
3. Tsang, A. et al. “Long‑term outcomes of argon plasma coagulation for gastric antral vascular ectasia.” Gastrointestinal Endoscopy 2022;95(4):823‑831. doi:10.1016/j.gie.2021.10.012
4. Cleveland Clinic. “Gastric Antral Vascular Ectasia (Watermelon Stomach).” Updated 2024. https://my.clevelandclinic.org/health/diseases/15747-gastric-antral-vascular-ectasia-gave
5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Upper GI Bleeding.” 2023. https://www.niddk.nih.gov/health-information/digestive-diseases/upper-gastrointestinal-bleeding

```